Suppr超能文献

p53活性增加不会加速端粒驱动的衰老。

Increased p53 activity does not accelerate telomere-driven ageing.

作者信息

García-Cao Isabel, García-Cao Marta, Tomás-Loba Antonia, Martín-Caballero Juan, Flores Juana M, Klatt Peter, Blasco María A, Serrano Manuel

机构信息

Tumor Suppression Group, Spanish National Cancer Center, Madrid.

出版信息

EMBO Rep. 2006 May;7(5):546-52. doi: 10.1038/sj.embor.7400667. Epub 2006 Mar 31.

Abstract

There is a great interest in determining the impact of p53 on ageing and, for this, it is important to discriminate among the known causes of ageing. Telomere loss is a well-established source of age-associated damage, which by itself can recapitulate ageing in mouse models. Here, we have used a genetic approach to interrogate whether p53 contributes to the elimination of telomere-damaged cells and its impact on telomere-driven ageing. We have generated compound mice carrying three functional copies of the p53 gene (super-p53) in a telomerase-deficient background and we have measured the presence of chromosomal abnormalities and DNA damage in several tissues. We have found that the in vivo load of telomere-derived chromosomal damage is significantly decreased in super-p53/telomerase-null mice compared with normal-p53/telomerase-null mice. Interestingly, the presence of extra p53 activity neither accelerates nor delays telomere-driven ageing. From these observations, we conclude that p53 has an active role in eliminating telomere-damaged cells, and we exclude the possibility of an age-promoting effect of p53 on telomere-driven ageing.

摘要

人们对确定p53对衰老的影响有着浓厚兴趣,为此,区分已知的衰老原因很重要。端粒损耗是与年龄相关损伤的一个公认来源,其本身就能在小鼠模型中重现衰老过程。在此,我们采用遗传学方法来探究p53是否有助于清除端粒受损细胞及其对端粒驱动衰老的影响。我们构建了在端粒酶缺陷背景下携带三个p53基因功能拷贝(超级p53)的复合小鼠,并检测了多个组织中染色体异常和DNA损伤的情况。我们发现,与正常p53/端粒酶缺失小鼠相比,超级p53/端粒酶缺失小鼠中端粒衍生的染色体损伤的体内负荷显著降低。有趣的是,额外的p53活性既不加速也不延迟端粒驱动的衰老。基于这些观察结果,我们得出结论,p53在清除端粒受损细胞中发挥着积极作用,并且我们排除了p53对端粒驱动衰老具有促进衰老作用的可能性。

相似文献

1
Increased p53 activity does not accelerate telomere-driven ageing.
EMBO Rep. 2006 May;7(5):546-52. doi: 10.1038/sj.embor.7400667. Epub 2006 Mar 31.
2
[Aging or tumor: the crosstalk between telomerase and p53].
Yi Chuan. 2009 May;31(5):451-6. doi: 10.3724/sp.j.1005.2009.00451.
3
Telomere dysfunction and Atm deficiency compromises organ homeostasis and accelerates ageing.
Nature. 2003 Feb 6;421(6923):643-8. doi: 10.1038/nature01385. Epub 2003 Jan 22.
4
Control of Cellular Aging, Tissue Function, and Cancer by p53 Downstream of Telomeres.
Cold Spring Harb Perspect Med. 2017 May 1;7(5):a026088. doi: 10.1101/cshperspect.a026088.
6
Telomere shortening in neural stem cells disrupts neuronal differentiation and neuritogenesis.
J Neurosci. 2009 Nov 18;29(46):14394-407. doi: 10.1523/JNEUROSCI.3836-09.2009.
8
Immunosenescence phenotypes in the telomerase knockout mouse.
Springer Semin Immunopathol. 2002;24(1):75-85. doi: 10.1007/s00281-001-0096-1.
9
Ink4a/Arf tumor suppressor does not modulate the degenerative conditions or tumor spectrum of the telomerase-deficient mouse.
Proc Natl Acad Sci U S A. 2007 Mar 6;104(10):3931-6. doi: 10.1073/pnas.0700093104. Epub 2007 Feb 27.

引用本文的文献

1
37 kDa LRP::FLAG enhances telomerase activity and reduces ageing markers in vivo.
Cell Mol Life Sci. 2025 Feb 22;82(1):83. doi: 10.1007/s00018-025-05593-0.
2
The Pivotal Role of One-Carbon Metabolism in Neoplastic Progression During the Aging Process.
Biomolecules. 2024 Oct 31;14(11):1387. doi: 10.3390/biom14111387.
3
Traditional herbs: mechanisms to combat cellular senescence.
Aging (Albany NY). 2023 Dec 5;15(23):14473-14505. doi: 10.18632/aging.205269.
5
Targeting USP2 regulation of VPRBP-mediated degradation of p53 and PD-L1 for cancer therapy.
Nat Commun. 2023 Apr 6;14(1):1941. doi: 10.1038/s41467-023-37617-3.
6
Breaking the aging epigenetic barrier.
Front Cell Dev Biol. 2022 Jul 28;10:943519. doi: 10.3389/fcell.2022.943519. eCollection 2022.
8
Cancer and Aging: Two Tightly Interconnected Biological Processes.
Cancers (Basel). 2021 Mar 19;13(6):1400. doi: 10.3390/cancers13061400.
9
AAV9-mediated telomerase activation does not accelerate tumorigenesis in the context of oncogenic K-Ras-induced lung cancer.
PLoS Genet. 2018 Aug 16;14(8):e1007562. doi: 10.1371/journal.pgen.1007562. eCollection 2018 Aug.
10
Jun dimerization protein 2 controls hypoxia-induced replicative senescence via both the p16-pRb and Arf-p53 pathways.
FEBS Open Bio. 2017 Oct 16;7(11):1793-1804. doi: 10.1002/2211-5463.12325. eCollection 2017 Nov.

本文引用的文献

1
Tumor suppression and normal aging in mice with constitutively high p53 activity.
Genes Dev. 2006 Jan 1;20(1):16-21. doi: 10.1101/gad.1378506.
2
Increased gene dosage of Ink4a/Arf results in cancer resistance and normal aging.
Genes Dev. 2004 Nov 15;18(22):2736-46. doi: 10.1101/gad.310304. Epub 2004 Nov 1.
3
Phosphorylation of H2AX at short telomeres in T cells and fibroblasts.
J Biol Chem. 2004 Oct 22;279(43):45148-54. doi: 10.1074/jbc.M403924200. Epub 2004 Aug 17.
4
Long lifespan in worms with long telomeric DNA.
Nat Genet. 2004 Jun;36(6):607-11. doi: 10.1038/ng1356. Epub 2004 May 2.
5
Modulation of mammalian life span by the short isoform of p53.
Genes Dev. 2004 Feb 1;18(3):306-19. doi: 10.1101/gad.1162404.
7
Telomeres, stem cells, senescence, and cancer.
J Clin Invest. 2004 Jan;113(2):160-8. doi: 10.1172/JCI20761.
8
Replicative senescence and the art of counting.
Exp Gerontol. 2003 Nov-Dec;38(11-12):1259-64. doi: 10.1016/j.exger.2003.09.015.
9
A DNA damage checkpoint response in telomere-initiated senescence.
Nature. 2003 Nov 13;426(6963):194-8. doi: 10.1038/nature02118. Epub 2003 Nov 5.
10
DNA damage foci at dysfunctional telomeres.
Curr Biol. 2003 Sep 2;13(17):1549-56. doi: 10.1016/s0960-9822(03)00542-6.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验